| ANF | alpha-naphthoflavone; American Nurses' Foundation; antineuritic factor; antinuclear factor; atrial n... |
|---|---|
| APF | acidulated phosphofluoride; American Psychological Foundation; anabolism-promoting factor; animal pr... |
| EPF | early pregnancy factor; endocarditis parietalis fibroplastica; endothelial proliferating factor; est... |
| HF | Hageman factor; haplotype frequency; hard filled [capsule]; hay fever; head of fetus; head forward; ... |
| IF | idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescen... |
edaphic factor
| capillary permeability factor | A mixture of bioflavonoids extracted from plants (especially citrus fruits). It reduces the permeability and fragility of capillaries and is useful in the treatment of certain cases of purpura that are resistant to vitamin C therapy. See: hesperidin, quercetin, rutin. Synonym: capillary permeability factor, citrin, permeability vitamin. (05 Mar 2000) |
|---|---|
| p60 tumour necrosis factor receptor-associated kinase | <enzyme> Interacts with and causes phosphorylation of the cytoplasmic domain of the tnf receptor Registry number: EC 2.7.10.- Synonym: p60 tnf receptor-associated kinase, p60-trak (26 Jun 1999) |
| galactagogue factor | <endocrinology> A factor in extracts of the posterior lobe of the hypophysis that, by stimulating the smooth muscle of the lobulo-alveolar system of the mammary gland, causes a flow of milk from the nipple. (05 Mar 2000) |
| galactopoietic factor | <protein> Pituitary lactogenic hormone (23 kD) Synthesised on endoplasmic reticulum bound ribosomes as preprolactin that has an N terminal signal peptide that is cleaved from the mature form. The conversion of preprolactin to prolactin has been much used as an assay for membrane insertion. (18 Nov 1997) |
| macrophage-activating factor | An agent that stimulates macrophages to attack and ingest cancer cells. They are secreted by stimulated lymphocytes that prime macrophages to become non-specifically cytotoxic to tumours. They also modulate the expression of macrophage cell surface ia antigens. One maf is interferon-gamma (interferon type II). Other factors antigenically distinct from ifn-gamma have also been identified. (12 Dec 1998) |
| macrophage colony-stimulating factor | <growth factor> A glycoprotein growth factor that causes the committed cell line to proliferate and mature into macrophages. A cytokine synthesised by mesenchymal cells that stimulates pluripotent stem cells of bone marrow into differentiating towards the production of monocytes (mononuclear phagocytes). The compound stimulates the survival, proliferation, and differentiation of haematopoietic cells of the monocyte-macrophage series. It is a disulfide-bonded glycoprotein dimer with a mw of 70 kD and binds to a single class of high affinity receptor which is identical to the product of the c-fms proto-oncogene. See: colony-stimulating factors. Chemical name: Colony-stimulating factor 1 Acronym: M-CSF (12 Dec 1998) |
| macrophage inhibition factor | <cytokine> A group of lymphokines (including a 14 kD glycoprotein) produced by activated T lymphocytes that reduces macrophage mobility and probably increases macrophage macrophage adhesion. (18 Nov 1997) |
| radiation weighting factor | In radiation protection, a factor weighting the absorbed dose of radiation of a specific type and energy for its effect on tissue. See: equivalent dose. (05 Mar 2000) |
| maise factor | <molecular biology, plant biology> A naturally occurring cytokinin, originally isolated from maize seeds. Its riboside is also a cytokinin. (18 Nov 1997) |
| vascular endothelial growth factor | A growth factor that is responsible for the growth of blood vessels. (12 Dec 1998) |
| mammotropic factor | <protein> Pituitary lactogenic hormone (23 kD) Synthesised on endoplasmic reticulum bound ribosomes as preprolactin that has an N terminal signal peptide that is cleaved from the mature form. The conversion of preprolactin to prolactin has been much used as an assay for membrane insertion. (18 Nov 1997) |
| receptors, atrial natriuretic factor | Cell surface proteins that bind atrial natriuretic factor with high affinity and trigger intracellular changes influencing the behaviour of cells. (12 Dec 1998) |
| receptors, colony-stimulating factor | Cell surface receptors for colony-stimulating factors, local mediators, and hormones that regulate the survival, proliferation, and differentiation of haemopoietic cells. (12 Dec 1998) |
| receptors, epidermal growth factor-urogastrone | Glycoproteins of about 170 kD that have protein kinase activity and span the plasma membranes of growing cells, including tumours. They are activated by the binding of epidermal growth factor-urogastrone which then initiates DNA and protein synthesis. They are not found on mitotically quiescent cells except in the stomach where they control the synthesis and release of digestive enzymes and gastric acid. Transforming growth factor alpha also binds to and activates these receptors. (12 Dec 1998) |
| receptors, fibroblast growth factor | Specific molecular sites or structures on cell membranes that react with fibroblast growth factors (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity. (12 Dec 1998) |
| risk factor |
Any characteristic, behavior, or condition which, based on history, utilization, or theory, is thought to directly influence susceptibility to a specific health problem, increase costs or result in increased utilization.
출처: www.pohly.com/terms_r.html
|
|---|---|
| risk factor |
Conditions for a group, individual, or defined geographic area that increase the likelihood of a substance use/abuse problem occurring (Achieving Outcomes, 12/01).
출처: wind.uwyo.edu/sig/definition.asp
|
| risk factor |
A risk factor is a trait or characteristic that increases your chances of developing a disease. Risk factors do not cause the disease, and not everyone who has a risk factor will get the disease. Doctors use risk factors to help focus risk reduction efforts on the people who are most "at risk" for the condition.
출처: www.thinprep.com/women/women_breast_cancer_glossar...
|
| risk factor |
Actions in the workplace, workplace conditions, or a combination thereof, that may cause or aggravate a Work Related Musculoskeletal Disorders; examples include forceful exertion, awkward postures, repetitive exertion, and environmental factors such as temperature.
출처: www.ergoweb.com/resources/faq/glossary.cfm
|
| risk factor |
anything that increases a person's chances of developing cancer. For example, smoking is a risk factor for lung, head/neck and cervical cancer.
출처: www.cancerboard.ab.ca/accsp/glossary.html
|